Blockade of TREM‐2 exacerbates experimental autoimmune encephalomyelitis
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Triggering receptor expressed on myeloid cells (TREM‐2) is a membrane receptor associated with DAP12 that is expressed primarily in myeloid cells, including dendritic cells and microglia, and promotes fusion of osteoclast precursors into multinucleated cells. A rare autosomal recessive condition, Nasu‐Hakola disease (NHD) is associated with loss‐of‐function mutations in DAP12 and TREM‐2. The brain pathology observed in NHD patients suggests that disruption of the TREM‐2/DAP12 pathway leads to neurodegeneration with demyelination and axonal loss. In this study, we have characterized TREM‐2 protein expression on microglia using a newly produced monoclonal antibody directed against the mouse TREM‐2 receptor. We report that TREM‐2 expression is up‐regulated in the spinal cord during both the early inflammatory and chronic phases of myelin oligodendrocyte glycoprotein (MOG)35–55 peptide‐induced experimental autoimmune encaphalomyelitis (EAE). We also demonstrate that TREM‐2 is highly expressed on microglial cells in the central nervous system (CNS) during EAE and that blockade of TREM‐2 during the effector phase of EAE results in disease exacerbation with more diffuse CNS inflammatory infiltrates and demyelination in the brain parenchyma. These results demonstrate a critical role for TREM‐2 during inflammatory responses in the CNS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These studies further support a role for microglia in the phagocytosis of myelin debris and potentially in subsequent axonal remyelination.”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [254]
In the citing paper
“TREM-2 is an important receptor involved in phagocytosis, and upon genetic absence or blockade of TREM-2, microglia fail to upregulate genes required for lipid metabolism and phagocytosis, resulting in the exacerbation of EAE [254, 255] (Table 6).”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [254]
In the citing paper
“Indeed, in EAE it has been shown that TREM2 is upregulated in spinal cord microglia and that an anti-TREM2 antibody exacerbates disease172.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [172]
Citations
Cites
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
Plat-E: an efficient and stable system for transient packaging of retroviruses
Morita, S., Kojima, T., & Kitamura, T. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301206 · Cited by 1,660
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Bouchon, A., Dietrich, J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4991 · Cited by 1,284
Self-citationAloisi, F. (2001) · Glia · doi:10.1002/glia.1106 · Cited by 1,280
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Greter, M., Heppner, F. L., Lemos, M. P., Odermatt, B. M., Goebels, N., Laufer, T., Noelle, R. J., & Becher, B. (2005) · Nature Medicine · doi:10.1038/nm1197 · Cited by 862
TREMs in the immune system and beyond
Colonna, M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1106 · Cited by 701
Self-citation
Cited by
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Microglial signatures and their role in health and disease
Butovsky, O., & Weiner, H. L. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0057-5 · Cited by 1,046
Debris clearance by microglia: an essential link between degeneration and regeneration
Neumann, H., Kotter, M. R., & Franklin, R. J. M. (2008) · Brain · doi:10.1093/brain/awn109 · Cited by 1,111
“during the effector phase of EAE results in disease exacerbation with more diffuse CNS inflammatory infiltrates and demyelination in the brain parenchyma (Piccio et al., 2007).”
The myeloid cells of the central nervous system parenchyma
Ransohoff, R. M., & Cardona, A. E. (2010) · Nature · doi:10.1038/nature09615 · Cited by 804
TREM2 — a key player in microglial biology and Alzheimer disease
Ulland, T. K., & Colonna, M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0072-1 · Cited by 735
Self-citationPhagocytosis of Microglia in the Central Nervous System Diseases
Fu, R., Shen, Q., Xu, P., Luo, J. J., & Tang, Y. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8620-6 · Cited by 652
“TREM-2 on microglia via binding with DNAXactivation protein 12 (DAP12), an ITAM-containing adaptor protein, triggers the reorganization of F-actin and phosphorylation of ERK/MAPK, mediating the clearance of apoptotic neurons [34, 35].”
BackgroundInefficient clearance of myelin debris by microglia impairs remyelinating processes
Lampron, A., Larochelle, A., Laflamme, N., Préfontaine, P., Plante, M.-M., Sánchez, M. G., Yong, V. W., Stys, P. K., Tremblay, M.-È., & Rivest, S. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141656 · Cited by 595
“Microglia and macrophages are regarded as detrimental in MS and experimental autoimmune encephalomyelitis (EAE) because of their roles in autoimmunity, such as antigen presentation and proinflammatory cytokine production (Fife et al., 2000;”
BackgroundInfluentialMicroglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology
Voet, S., Prinz, M., & van Loo, G. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.11.005 · Cited by 503
New insights into the role of TREM2 in Alzheimer’s disease
Gratuze, M., Leyns, C. E. G., & Holtzman, D. M. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0298-9 · Cited by 489
Microbiome–microglia connections via the gut–brain axis
Abdel-Haq, R., Schlachetzki, J. C. M., Glass, C. K., & Mazmanian, S. K. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180794 · Cited by 471
A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia
Hsieh, C. L., Koike, M., Spusta, S. C., Niemi, E. C., Yenari, M., Nakamura, M. C., & Seaman, W. E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06042.x · Cited by 475
“In this regard, blockade of TREM2 has been shown to exacerbate EAE, while infusion of TREM2+ cells improves it (Piccio et al. 2007; Takahashi et al. 2007).”
BackgroundInfluentialTREM2, microglia, and neurodegenerative diseases
Yeh, F. L., Hansen, D. V., & Sheng, M. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.03.008 · Cited by 440
“An intraperitoneal injection of an anti-TREM2 blocking antibody was found to exacerbate disease severity in mice, implying that TREM2 might play a protective role in the disease [145].”
BackgroundTREM and TREM-like receptors in inflammation and disease
Ford, J. W., & McVicar, D. W. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.009 · Cited by 434
TREM2 variants: new keys to decipher Alzheimer disease pathogenesis
Colonna, M., & Wang, Y. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.7 · Cited by 418
“Finally, clinical symptoms in an experimental mouse model of autoimmune encephalitis improved after adoptive transfer of myeloid cells expressing TREM2 but became worse after TREM2 blockade with a monoclonal antibody (Piccio et al., 2007; Takahashi et al., 2007).”
BackgroundSelf-citationMicroglial Activation in Stroke: Therapeutic Targets
Yenari, M. A., Kauppinen, T. M., & Swanson, R. A. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.005 · Cited by 389
Microglia Mediated Neuroinflammation in Parkinson’s Disease
Isik, S., Yeman Kiyak, B., Akbayir, R., Seyhali, R., & Arpaci, T. (2023) · Cells · doi:10.3390/cells12071012 · Cited by 379
Chen, S., Peng, J., Sherchan, P., Ma, Y., Xiang, S., Yan, F., Zhao, H., Jiang, Y., Wang, N., Zhang, J. H., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01853-x · Cited by 379
“A previous study reported that TREM2 deficiency exacerbated uncontrolled inflammation in a model of autoimmune encephalomyelitis [45].”
Kawabori, M., Kacimi, R., Kauppinen, T., Calosing, C., Kim, J. Y., Hsieh, C. L., Nakamura, M. C., & Yenari, M. A. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2620-14.2015 · Cited by 375
“TREM2 also appears to signal through anti-inflammatory pathways, and its deficiency leads to uncontrolled inflammation in a model of experimental autoimmune encephalomyelitis (EAE; Piccio et al., 2007).”
BackgroundSilvin, A., Uderhardt, S., Piot, C., Da Mesquita, S., Yang, K., Geirsdottir, L., Mulder, K., Eyal, D., Liu, Z., Bridlance, C., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.07.004 · Cited by 368
Microglia and ischemic stroke: a double-edged sword.
Patel, A. R., Ritzel, R. M., McCullough, L. D., & Liu, F. (2013) · Europe PMC (PubMed Central) · Cited by 406
Elucidating the Role of TREM2 in Alzheimer’s Disease
Ulrich, J. D., Ulland, T. K., Colonna, M., & Holtzman, D. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.042 · Cited by 325
“Inhibition of TREM2 in the EAE model resulted in a more severe clinical phenotype, suggesting a potential protective role for TREM2 (Piccio et al., 2007).”
BackgroundResultSelf-citationCerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
Piccio, L., Deming, Y., Del-Águila, J. L., Ghezzi, L., Holtzman, D. M., Fagan, A. M., Fenoglio, C., Galimberti, D., Borroni, B., & Cruchaga, C. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1533-5 · Cited by 337
“TREM2 is expressed on microglia [38, 39], with the release of sTREM2 in the extracellular space mainly due to proteolytic cleavage of the surface receptor [27].”
BackgroundSelf-citationMyeloid Cells in the Central Nervous System
Herz, J., Filiano, A. J., Wiltbank, A. T., Yogev, N., & Kipnis, J. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.007 · Cited by 332
Role of the innate immune system in the pathogenesis of multiple sclerosis
Gandhi, R., Laroni, A., & Weiner, H. L. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.10.015 · Cited by 331
“Along a similar line, TREM2 (Triggering receptor expressed on myeloid cells-2), is a microglial/macrophage specific membrane-bound receptor involved in reducing inflammation and promoting phagocytosis (Piccio et al., 2007).”
BackgroundJiang, T., Tan, L., Zhu, X.-C., Zhang, Q.-Q., Cao, L., Tan, M.-S., Gu, L.-Z., Wang, H.-F., Ding, Z.-Z., Zhang, Y.-D., et al. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.164 · Cited by 320
Inflammation after Ischemic Stroke: The Role of Leukocytes and Glial Cells
Kim, J. Y., Park, J., Chang, J. Y., Kim, S.-H., & Lee, J. E. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.5.241 · Cited by 309
“T lymphocyte - activity-dependent synaptic pruing and repair - morphologic transformation in acute brain injury - sweep foregin organism in brain injury - role of M1 phenotype microglia in the brain - role of M2 phenotype microglia in the brain - swith of M1 to M2 microglia - microglia functionin ischemic stroke - reg…”
BackgroundPiccio, L., Buonsanti, C., Cella, M., Tassi, I., Schmidt, R. E., Fenoglio, C., Rinker, J., Naismith, R. T., Panina-Bordignon, P., Passini, N., et al. (2008) · Brain · doi:10.1093/brain/awn217 · Cited by 307
“Our group and another have recently demonstrated that TREM-2 expression on microglia and macrophages in the CNS exerts a protective effect during experimental autoimmune encephalomyelitis (EAE), the leading animal model of multiple sclerosis.”
BackgroundInfluentialSelf-citationPhagocytosis in the Brain: Homeostasis and Disease
Galloway, D. A., Phillips, A. E. M., Owen, D. R. J., & Moore, C. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00790 · Cited by 307
Immune Regulation in the Aging Retina
Chen, M., Luo, C., Zhao, J., Devarajan, G., & Xu, H. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.10.003 · Cited by 305
“Furthermore, it plays a positive role in the phagocytosis of dead neurons and is critically involved in CNS homeostasis (Piccio et al., 2007).”
Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
Ulrich, J. D., Finn, M. B., Wang, Y., Shen, A., Mahan, T. E., Jiang, H., Stewart, F. R., Piccio, L., Colonna, M., & Holtzman, D. M. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-20 · Cited by 302
“Within the brain, TREM2 is expressed by microglia and appears to regulate microglial-mediated phagocytic clearance of cellular debris and the inflammatory response of microglia to pathology, however the endogenous ligand(s) for TREM2 are unknown [7-10].”
BackgroundSelf-citationMicroglial TREM2/DAP12 signaling: a double-edged sword in neural diseases
Konishi, H., & Kiyama, H. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00206 · Cited by 300
“Inflammation was promoted and the EAE clinical score and demyelination were worsened by intraperitoneal injection of a TREM2 functional blocking antibody (Piccio et al., 2007).”
BackgroundMicroglia in Alzheimer Disease: Well-Known Targets and New Opportunities
Hemonnot, A.-L., Hua, J., Ulmann, L., & Hirbec, H. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00233 · Cited by 298
“, 2005) and was shown to modulate inflammation (Piccio et al., 2007), phagocytosis (Takahashi et al.”
BackgroundTREM2 regulates microglial cell activation in response to demyelination in vivo
Cantoni, C., Bollman, B., Licastro, D., Xie, M., Mikesell, R., Schmidt, R., Yuede, C. M., Galimberti, D., Olivecrona, G., Klein, R. S., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1388-1 · Cited by 296
“TREM2 could directly mediate this interaction as astrocytes have been shown to express binding sites for TREM2 [11, 63].”
TREM2-Ligand Interactions in Health and Disease
Kober, D. L., & Brett, T. J. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.04.004 · Cited by 284
Macrophage subsets and microglia in multiple sclerosis
Bogie, J. F. J., Stinissen, P., & Hendriks, J. J. A. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1310-2 · Cited by 251
Arcuri, C., Mecca, C., Bianchi, R., Giambanco, I., & Donato, R. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00191 · Cited by 279
“…signaling pathways and/or intracellular mediators is missing, TREM2 engagement in microglia leads to the reorganization of F-actin and phosphorylation of ERK1/2, by binding to DNAX activation protein 12 (DAP12), thereby mediating the clearance of apoptotic neurons (Piccio et al., 2007) (Figure 2).”
BackgroundRole of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target
Du, L., Zhang, Y., Chen, Y., Zhu, J., Yang, Y., & Zhang, H.-L. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0245-0 · Cited by 262
“mediate a protective function [58] [59] [60].”
Microglia and aging: the role of the TREM2-DAP12 and CX3CL1-CX3CR1 axes
Mecca, C., Giambanco, I., Donato, R., & Arcuri, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010318 · Cited by 258
Teeling, J. L., & Perry, V. H. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.031 · Cited by 252
TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice
Frank, S., Burbach, G. J., Bonin, M., Walter, M., Streit, W., Bechmann, I., & Deller, T. (2008) · Glia · doi:10.1002/glia.20710 · Cited by 247
“…debris, but also contribute significantly to secondary tissue injury, immune cells are tightly controlled within the neuropil (Bechmann, 2005; Bechmann et al., 2007; Galea et al., 2007) and the recent appreciation of anti-inflammatory responses in AD (Ray et al., 2007) is consistent with this view.”
ResultTREM-1: intracellular signaling pathways and interaction with pattern recognition receptors
Arts, R. J. W., Joosten, L. A. B., van der Meer, J. W. M., & Netea, M. G. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0312145 · Cited by 232
“In contrast to TREM-1, TREM-2 is only expressed on immature DCs, bone marrow-derived macrophages, macrophage cell lines, and microglia [74–76].”
ResultEmerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer’s Disease
Lewcock, J. W., Schlepckow, K., Di Paolo, G., Tahirovic, S., Monroe, K. M., & Haass, C. (2020) · Neuron · doi:10.1016/j.neuron.2020.09.029 · Cited by 221
Natrajan, M. S., de la Fuente, A. G., Crawford, A. H., Linehan, E., Nuñez, V., Johnson, K. R., Wu, T., Fitzgerald, D. C., Ricote, M., Bielekova, B., et al. (2015) · Brain · doi:10.1093/brain/awv289 · Cited by 218
TREM2, microglia, and Alzheimer’s disease.
Qin, Q., Teng, Z., Liu, C., Li, Q., Yin, Y., & Tang, Y. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111438 · Cited by 219
Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function
Spiteri, A. G., Wishart, C. L., Pamphlett, R., Locatelli, G., & King, N. J. C. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02384-2 · Cited by 244
“TREM-2 is an important receptor involved in phagocytosis, and upon genetic absence or blockade of TREM-2, microglia fail to upregulate genes required for lipid metabolism and phagocytosis, resulting in the exacerbation of EAE [254, 255] (Table 6).”
BackgroundVoß, E. V., Škuljec, J., Gudi, V., Skripuletz, T., Pul, R., Trebst, C., & Stangel, M. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.09.008 · Cited by 202
“In EAE antibody-mediated blockade of TREM-2 during the effector phase results in exacerbation of disease (Piccio et al., 2007) and the intravenous application of TREM-2-transduced myeloid cells leads to amelioration of EAE associated with increased myelin phagocytosis (Takahashi et al.”
BackgroundAmyloid-β and Tau at the Crossroads of Alzheimer’s Disease
Gallardo, G., & Holtzman, D. M. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-32-9358-8_16 · Cited by 198
From expression to signaling: Roles of TREM-1 and TREM-2 in innate immunity and bacterial infection
Sharif, O., & Knapp, S. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.07.008 · Cited by 196
Ashique, S., Mohanto, S., Ahmed, M. G., Mishra, N., Garg, A., Chellappan, D. K., Omara, T., Iqbal, S., & Kahwa, I. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34092 · Cited by 185
“[34]”
RetractedLandel, V., Baranger, K., Virard, I., Loriod, B., Khrestchatisky, M., Rivera, S., Benech, P., & Féron, F. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-33 · Cited by 176
“The second Trem2 signaling pathway suppresses inflammatory reactivity and represses cytokine production and secretion [144], notably TLR-and FcR-induced TNF production [146,147].”
Dower, K., Ellis, D. K., Saraf, K., Jelinsky, S. A., & Lin, L.-L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3520 · Cited by 175
“Indeed, in microglial cells TREM-2 promotes phagocytosis while suppressing proinflammatory cytokine production (32), and TREM-2 expression dampens inflammation in mouse models of multiple sclerosis (8, 33).”
BackgroundProtective effects of microglia in multiple sclerosis
Napoli, I., & Neumann, H. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.024 · Cited by 175
Identification of Epigenetically Altered Genes in Sporadic Amyotrophic Lateral Sclerosis
Figueroa-Romero, C., Hur, J., Bender, D. E., Delaney, C. E., Cataldo, M. D., Smith, A. L., Yung, R., Ruden, D. M., Callaghan, B. C., & Feldman, E. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052672 · Cited by 161
Sen, M. K., Mahns, D. A., Coorssen, J. R., & Shortland, P. J. (2022) · Glia · doi:10.1002/glia.24148 · Cited by 159
Genetics of Alzheimer's Disease
Guerreiro, R., & Hardy, J. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0295-9 · Cited by 155
“The other signaling stream suppresses inflammatory reactivity and involves the repression of cytokine production and secretion [35–37].”
BackgroundSystemic Inflammation Modulates Fc Receptor Expression on Microglia during Chronic Neurodegeneration
Lunnon, K., Teeling, J. L., Tutt, A. L., Cragg, M. S., Glennie, M. J., & Perry, V. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903833 · Cited by 138
Lue, L., Schmitz, C. T., Serrano, G., Sue, L. I., Beach, T. G., & Walker, D. G. (2015) · Brain Pathology · doi:10.1111/bpa.12190 · Cited by 154
“This has been supported by the evidence from animal models of multiple sclerosis (37, 45).”
ResultTREM2 Function in Alzheimer’s Disease and Neurodegeneration
Ulrich, J. D., & Holtzman, D. M. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00313 · Cited by 154
The surface‐exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor
Stefano, L., Racchetti, G., Bianco, F., Passini, N., Gupta, R. S., Bordignon, P. P., & Meldolesi, J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06130.x · Cited by 152
“…modified Dulbecco’s medium (Invitrogen Life Technologies) were supplemented with the two antibiotics and with 2 mM L-glutamine; BWZ.36 cells, transfected or not with TREM2 and DAP12 (Piccio et al. 2007) were grown in RPMI-1640 medium containing 10% fetal calf serum and the antibiotic mixture.”
BackgroundMethodInfluentialSelf-citationMicroglial autophagy–associated phagocytosis is essential for recovery from neuroinflammation
Berglund, R., Guerreiro-Cacais, A. O., Adzemovic, M. Z., Zeitelhofer, M., Lund, H., Ewing, E., Ruhrmann, S., Nutma, E., Parsa, R., Thessen-Hedreul, M., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abb5077 · Cited by 149
Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis
Wang, J., Wang, J., Wang, J., Yang, B., Weng, Q., & He, Q. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00286 · Cited by 147
“…supportive and neuroprotective roles in MS. Selective elimination of both perivascular and meningeal macrophages by treatment with clodronate-loaded liposomes reduces the progression of EAE in rats (Polfliet et al., 2002), suggesting that perivascular macrophages may act as competent APCs in EAE.”
BackgroundBhattacharjee, S., Zhao, Y., Dua, P., Rogaev, E. I., & Lukiw, W. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150211 · Cited by 147
“Specific up-regulation of miRNA-34a-signalling has been previously associated with at least 15 neurological, neuroimmune, neuro-inflammatory and/or neurodegenerative pathologies including (i) diseased spinal cord tissues in amyotrophic lateral sclerosis [11]; (ii) peripheral blood mononuclear cells and blood plasma in…”
The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis
Mallucci, G., Peruzzotti-Jametti, L., Bernstock, J. D., & Pluchino, S. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.02.003 · Cited by 145
“The presence of microglia/macrophages in every step of the evolving GM lesion suggests a role for mononuclear cells in clearing the environment of growth inhibitory molecules (Piccio et al., 2007; Takahashi et al., 2007).”
Durrenberger, P. F., Fernando, F. S., Kashefi, S. N., Bonnert, T. P., Seilhean, D., Nait-Oumesmar, B., Schmitt, A., Gebicke-Haerter, P. J., Falkai, P., Grünblatt, E., et al. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1293-0 · Cited by 139
Protective Microglial Subset in Development, Aging, and Disease: Lessons From Transcriptomic Studies
Benmamar-Badel, A., Owens, T., & Wlodarczyk, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00430 · Cited by 124
“Moreover, decreasing CD11c+ microglia by blocking of TREM2 signaling (as discussed below) led to increased severity of EAE and exacerbated demyelinating lesions in the spinal cord (142) , further supporting protective roles of CD11c+ microglia.”
BackgroundMelchior, B., Garcia, A. E., Hsiung, B.-K., Lo, K. M., Doose, J. M., Thrash, J. C., Stalder, A. K., Staufenbiel, M., Neumann, H., & Carson, M. J. (2010) · ASN Neuro · doi:10.1042/an20100010 · Cited by 134
“With specific relevance to CNS disease, overexpressing TREM2 in peripheral antigen-presenting cells did decrease the severity and speeded the recovery from EAE (experimentally induced autoimmune encephalomyelitis) (Takahashi et al., 2007).”
BackgroundInfluentialAlzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy
Clayton, K. A., Van Enoo, A. A., & Ikezu, T. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00680 · Cited by 134
“, 2012), whereas triggering receptor expressed on myeloid cells 2 (TREM2), is known to control microglia-mediated Aβ compaction, and phagocytosis of apoptotic neurons (Piccio et al., 2007; Takahashi et al., 2007; Yuan et al., 2016).”
BackgroundSoluble TREM2: Innocent bystander or active player in neurological diseases?
Filipello, F., Goldsbury, C., You, S. F., Locca, A., Karch, C. M., & Piccio, L. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105630 · Cited by 134
Self-citationHu, X., Liou, A. K. F., Leak, R. K., Xu, M., An, C., Suenaga, J., Shi, Y., Gao, Y., Zheng, P., & Chen, J. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.06.002 · Cited by 131
Retinal microglia: Functions and diseases
Fan, W., Huang, W., Chen, J., Li, N., Mao, L., & Hou, S. (2022) · Immunology · doi:10.1111/imm.13479 · Cited by 163
“Sclerosis/EAE Degenerated myelin TREM-2; CR3; Galectin3/MAC-2 Clearance of apoptotic neurons and degenerated myelin [206,207]”
BackgroundThe expanding roles of ITAM adapters FcRγ and DAP12 in myeloid cells
Hamerman, J. A., Ni, M., Killebrew, J. R., Chu, C., & Lowell, C. A. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00841.x · Cited by 129
“Treatment of mice with a blocking antibody to TREM-2 results in exacerbation of EAE as measured by clinical score (96).”
BackgroundMethodMicroglia: unique and common features with other tissue macrophages
Prinz, M., Tay, T. L., Wolf, Y., & Jung, S. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1267-1 · Cited by 126
“In support of these findings, another study detected enhanced expression of TReM-2 on microglia during eAe and that blockade of the receptor exacerbated disease progression [100].”
ResultMechanisms and Potential Therapeutic Applications of Microglial Activation after Brain Injury
Kim, J., Kim, N., & Yenari, M. A. (2015) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12360 · Cited by 118
“Restriction of TREM2 using a monoclonal antibody in experimental autoimmune encephalomyelitis resulted in exacerbation of immune responses with increased demyelination and worsened neurological function [83].”
BackgroundResultRen, M., Guo, Y., Wei, X., Yan, S., Qin, Y., Zhang, X., Jiang, F., & Lou, H. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.01.016 · Cited by 126
“TREM2 appears to signal through anti-inflammatory pathways (Walter, 2016), and its deficiency leads to uncontrolled inflammation in a model of experimental autoimmune encephalomyelitis (Piccio et al., 2007).”
Jiang, T., Yu, J., Zhu, X., & Tan, L. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8424-8 · Cited by 131
“In animal models of multiple sclerosis and autoimmune encephalomyelitis, increased expression of TREM2 on microglia was coupled to enhance phagocytic pathways and promote the M2-like activation state of microglia, which was thought to has protective effects [37, 38].”
BackgroundAminophospholipids are signal-transducing TREM2 ligands on apoptotic cells
Shirotani, K., Hori, Y., Yoshizaki, R., Higuchi, E., Colonna, M., Saito, T., Hashimoto, S., Saito, T., Saido, T. C., & Iwata, N. (2019) · Scientific Reports · doi:10.1038/s41598-019-43535-6 · Cited by 116
Self-citationCarson, M. J., Bilousova, T. V., Puntambekar, S. S., Melchior, B., Doose, J. M., & Ethell, I. M. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.07.002 · Cited by 135
Roles and regulation of microglia activity in multiple sclerosis: insights from animal models
Distéfano-Gagné, F., Bitarafan, S., Lacroix, S., & Gosselin, D. (2023) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00709-6 · Cited by 91
TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
Del-Aguila, J. L., Benitez, B. A., Li, Z., Dube, U., Mihindukulasuriya, K. A., Budde, J. P., Farias, F. H. G., Fernández, M. V., Ibanez, L., Jiang, S., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0319-3 · Cited by 109
The Molecular Basis for Remyelination Failure in Multiple Sclerosis
Gruchot, J., Weyers, V., Göttle, P., Förster, M., Hartung, H.-P., Küry, P., & Kremer, D. (2019) · Cells · doi:10.3390/cells8080825 · Cited by 109
“In addition, in the inflammatory setting of EAE, a blockade of TREM2 leads to disease progression, resulting in diffuse demyelination [105].”
BackgroundIncreased Expression of TREM2 in Peripheral Blood of Alzheimer's Disease Patients
Hu, N., Tan, M.-S., Yu, J.-T., Sun, L., Tan, L., Wang, Y.-L., Jiang, T., & Tan, L. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130854 · Cited by 108
“Increased expression of TREM2 on microglia is coupled to enhanced phagocytosis and promotion of the alternative activation state of microglia, which is thought to be protective [23, 24].”
Bar, E., & Barak, B. (2019) · Glia · doi:10.1002/glia.23637 · Cited by 107
“Consistent with these findings, in an EAE mouse model, blocking TREM2 function resulted in the accumulation of myelin debris that continuously recruited non-engulfing microglia (Piccio et al., 2007).”
ResultTriggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity?
Roe, K., Gibot, S., & Verma, S. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00627 · Cited by 119
“…anti-inflammatory and protective functions of TREM-2 have been proposed for other acute neuroinflammatory diseases, such as multiple sclerosis (Piccio et al., 2007) and Alzheimer’s disease (Guerreiro et al., 2013; Jonsson et al., 2013), implying that alterations in the immune homeostasis may…”
BackgroundRosciszewski, G., Cadena, V., Murta, V., Lukin, J., Villarreal, A., Roger, T., & Ramos, A. J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0618-z · Cited by 105
Structure, expression pattern and biological activity of molecular complex TREM-2/DAP12
Paradowska-Gorycka, A., & Jurkowska, M. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.02.003 · Cited by 103
“Microglial cells are involved in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), where TREM-2, through the regulatory mechanisms that control excessive inflammation, plays a role not only during the early inflammation phase but also during the chronic phase [42].”
BackgroundInfluentialAnimal Models of MS Reveal Multiple Roles of Microglia in Disease Pathogenesis
Gao, Z., & Tsirka, S. E. (2011) · Neurology Research International · doi:10.1155/2011/383087 · Cited by 103
“In this review, we discuss functions of microglia in MS, EAE and other experimental studies and review evidence implicating the critical roles of microglia in the complicated neural-immune networks.”
BackgroundThrash, J. C., Torbett, B. E., & Carson, M. J. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9657-1 · Cited by 110
Merson, T. D., Binder, M. D., & Kilpatrick, T. J. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8112-z · Cited by 84
“…and induction of anti-inflammatory cytokine production which has been implicated in lessening the clinical severity of EAE, inflammatory infiltration, demy- elination and axonal damage, making it an attractive therapeutic target to promote repair (Piccio et al. 2007; Takahashi et al. 2007).”
BackgroundÖhrfelt, A., Axelsson, M., Malmeström, C., Novakova, L., Heslegrave, A., Blennow, K., Lycke, J., & Zetterberg, H. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458515624558 · Cited by 98
Zhai, Q., Li, F., Chen, X., Jia, J., Sun, S., Zhou, D., Ma, L., Jiang, T., Bai, F., Xiong, L., et al. (2017) · Anesthesiology · doi:10.1097/aln.0000000000001628 · Cited by 98
Thompson, K., & Tsirka, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030504 · Cited by 93
Fueling neurodegeneration: metabolic insights into microglia functions
Sadeghdoust, M., Das, A., & Kaushik, D. K. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03296-0 · Cited by 118
“Also, TREM2 expression increased in microglia during EAE [130], and its inhibition during the effector phase of EAE was associated with widespread inflammation and demyelination in the brain [131].”
Pelham, C. J., & Agrawal, D. K. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.866519 · Cited by 97
Chen, Q., Zhang, K., Jin, Y., Zhu, T., Cheng, B., Shu, Q., & Fang, X. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-1967oc · Cited by 86
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis
Giunti, D., Parodi, B., Cordano, C., Uccelli, A., & Kerlero de Rosbo, N. (2014) · Immunology · doi:10.1111/imm.12177 · Cited by 85
The Evolving Biology of Microglia in Alzheimer's Disease
Malm, T. M., Jay, T. R., & Landreth, G. E. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0316-8 · Cited by 85
“Others have examined changes in Trem2-deficient mice in the context of stroke and shown increased inflammation in Trem2 mice [143], whereas blocking Trem2 using a monoclonal antibody in the context of EAE blocked infiltration of peripheral immune cells and ameliorated pathology [144].”
BackgroundPathological differences between white and grey matter multiple sclerosis lesions
Prins, M., Schul, E., Geurts, J., van der Valk, P., Drukarch, B., & van Dam, A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12841 · Cited by 84
TREM Receptors Connecting Bowel Inflammation to Neurodegenerative Disorders
Natale, G., Biagioni, F., Busceti, C. L., Gambardella, S., Limanaqi, F., & Fornai, F. (2019) · Cells · doi:10.3390/cells8101124 · Cited by 89
“This is reminiscent of what occurs in mice with experimental autoimmune encephalomyelitis (EAE), where TREM-2 is highly expressed on microglial cells and macrophages, while its blockade exacerbates the inflammatory process [78,79].”
ResultFarah, M. H., Pan, B. H., Hoffman, P. N., Ferraris, D., Tsukamoto, T., Nguyen, T., Wong, P. C., Price, D. L., Slusher, B. S., & Griffin, J. W. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6810-10.2011 · Cited by 81
“TREM2 on the membrane of macrophages is believed to be the active form and cell surface TREM2 is associated with phagocytosis (Turnbull et al., 2006; Piccio et al., 2007; Hsieh et al., 2009).”
BackgroundModels of multiple sclerosis: new insights into pathophysiology and repair
Lassmann, H. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282fee94a · Cited by 81
Metadata
- Authors
- Piccio, L., Buonsanti, C., Mariani, M., Cella, M., Gilfillan, S., Cross, A. H., Colonna, M., & Panina‐Bordignon, P.
- Affiliations
- University of Milan (IT)
- Washington University in St. Louis (US)
- Corresponding author
- Panina‐Bordignon, Paola
- ORCID
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2007-04-19
- Volume
- 37
- Issue
- 5
- Pages
- 1290-1301
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2090134990
- Cited by
- 284
- References
- 51
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 16 · 2023: 13 · 2022: 25 · 2021: 20 · 2020: 17 · 2019: 14 · 2018: 21 · 2017: 16 · 2016: 17 · 2015: 14 · 2014: 27 · 2013: 17 · 2012: 9
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- TREM2, DAP12, experimental autoimmune encephalomyelitis, microglia, demyelination, myelin oligodendrocyte glycoprotein, Nasu-Hakola disease, neuroinflammation, monoclonal antibodies, myeloid cells
- MeSH terms
- Animals, Brain, Encephalomyelitis, Autoimmune, Experimental, Fluorescent Antibody Technique, Macrophages, Membrane Glycoproteins, Receptors, Immunologic, RNA, Messenger, Spinal Cord, Blotting, Northern, Up-Regulation, Microglia, Reverse Transcriptase Polymerase Chain Reaction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.